Title : Targeting the epidermal growth factor receptor for head and neck cancer chemoprevention.

Pub. Date : 2014 Oct

PMID : 24412287






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Clinical trials with EGFR targeted agents, including cetuximab, erlotinib, and vandetanib, are currently under way, some with promising preliminary results. vandetanib epidermal growth factor receptor Homo sapiens